| ★ | Expedited Investigational New Drug (IND) pilot program webinar | U.S. Food and Drug Administration @us_fda | 4.7K | Estados Unidos | |
| 19 | 12.2025 Part 2: Battle to once weekly insulin approval – insulin icodec | aphapharmacists @aphapharmacists | — | — | 83 |
| 1 | Streamline the Drug Development Pipeline - Accelerating Innovation in Healthcare | BioTech Whisperer @biotechwhisperer | 4.0K | Estados Unidos | 85 |
| 13 | GDF2026 - Updates on Nitrosamines/ Nitrosamine Mitigation Strategies for Pharmaceuticals | U.S. Food and Drug Administration @us_fda | 409 | Estados Unidos | 83 |
| 10 | Understanding the FDA's Plausible Mechanism Framework | National Organization for Rare Disorders (NORD) @raredisorders | 276 | Estados Unidos | 83 |
| 5 | RaDAR: Rapid Drug Analysis and Research (RaDAR) Program | National Institute of Standards and Technology @nist | 232 | Estados Unidos | 84 |
| 9 | Understanding the Drug Development Pipeline (9 Minutes) | BioTech Whisperer @biotechwhisperer | 232 | Estados Unidos | 84 |
| 14 | GDF2026 - Bioequivalence (BE) Recommendations for Bridging Pre- and Post-Mitigation Formulations | U.S. Food and Drug Administration @us_fda | 160 | Estados Unidos | 83 |
| 7 | Screening for Lead Compounds (10 Minutes) | BioTech Whisperer @biotechwhisperer | 130 | Estados Unidos | 84 |
| 20 | GDF2026 - An Update on CDER’s Quality Management Maturity (QMM) Program | U.S. Food and Drug Administration @us_fda | 109 | Estados Unidos | 83 |
| 17 | GDF2026 - Pre-Abbreviated New Drug Application (ANDA) Meetings for Complex Drug Products | U.S. Food and Drug Administration @us_fda | 101 | Estados Unidos | 83 |
| 12 | Integrating Health Services to Accelerate the Elimination of Communicable Diseases in the Americas | | 95 | Estados Unidos | 83 |
| 16 | Diabetes Dialogue: The International Diabetes Federation and Care in India, With Amit Gupta, MBBS | | 79 | Estados Unidos | 83 |
| 18 | 12.2025 Part 1: Battle to once weekly insulin approval – insulin efsitora alfa | aphapharmacists @aphapharmacists | 70 | — | 83 |
| 15 | GDF2026 - Drug-Device Combination Products: A Quality Perspective | U.S. Food and Drug Administration @us_fda | 64 | Estados Unidos | 83 |
| 4 | GDF2026 - Prioritization Requests: Prioritizing Original and Supplemental ANDAs | U.S. Food and Drug Administration @us_fda | 49 | Estados Unidos | 84 |
| 2 | GDF2026 - Using FDA’s Inactive Ingredient Database (IID): Best Practices and Considerations | U.S. Food and Drug Administration @us_fda | 47 | Estados Unidos | 85 |
| 8 | Understanding the Drug Discovery Process (3 Minutes) | BioTech Whisperer @biotechwhisperer | 41 | Estados Unidos | 84 |
| 11 | What Is A Clinical Trial? | The Partnership In Education @thepartnershipineducation | 37 | Estados Unidos | 83 |
| 3 | Whitepaper: Accelerating access: Expedited and harmonised pathways for innovative therapies | | 19 | Irlanda | 85 |
| 6 | Introduction to Drug Development (14 Minutes) | Microlearning Daily @microlearningdaily | 15 | Singapur | 84 |